gamma delta T-cell therapy (Beijing Doing Biomedical Technology)

N/A

Report date: 2025/03/20 15:49:44

Base Information

Drug Namegamma delta T-cell therapy (Beijing Doing Biomedical Technology)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Gamma delta T-cell therapy

Mechanisms of ActionT lymphocytes stimulantsImmunostimulants

TargetsUpdating

Therapy Area/IndicationsStomach Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesBeijing Doing Biomedical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesBeijing Doing Biomedical Co Ltd

Inactive CompaniesN/A

Active IndicationsStomach Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A